Versant Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Versant Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,829	Closed	-$7K	–	1863
2019 Q4	$7K	Sell	1,829 -668	-27%	-$3.14K	﹤0.01%	858
2019 Q3	$12K	Buy	2,497 +1,160	+87%	+$6.49K	0.01%	659
2019 Q2	$8K	Buy	1,337 +1,143	+589%	+$6.08K	﹤0.01%	841
2019 Q1	$1K	Sell	194 -1,348	-87%	-$13.9K	﹤0.01%	1523
2018 Q4	$20K	Buy	1,542 +15	+1%	+$253	0.01%	546
2018 Q3	$29K	Sell	1,527 -176	-10%	-$3.75K	0.01%	474
2018 Q2	$43K	Buy	1,703 +11	+0.7%	+$256	0.02%	347
2018 Q1	$34K	Sell	1,692 -35	-2%	-$817	0.01%	424
2017 Q4	$34K	Sell	1,727 -281	-14%	-$5.53K	0.01%	437
2017 Q3	$41K	Buy	2,008 +401	+25%	+$6.78K	0.02%	319
2017 Q2	$23K	Buy	1,607 +668	+71%	+$11.1K	0.01%	544
2017 Q1	$14K	Buy	+939	New	+$13.5K	0.01%	733

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Versant Capital Management's DPLO Position: Q1 2020 in Review

Versant Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,829 shares — an estimated $7K sold.

Versant Capital Management first reported a position in DPLO in Q1 2017 and held it in 12 quarters. The position peaked at $43K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Versant Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Versant Capital Management sold 1,829 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $7K.
Versant Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 12 quarters.
Versant Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $43K in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Versant Capital Management's 13F filing for Q1 2020, filed 17 Apr 2020.